[1]
Tabatabai, E. et al. 2021. Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer . EXCLI Journal. 20, (May 2021), 863–878. DOI:https://doi.org/10.17179/excli2021-3421.